Letter to the Editor in Response to Gondrand Et al. “Real‐Life Application of a Point‐of‐Care Biosensor for Phenylalanine in Patients With Phenylketonuria”
Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)
DOI: 10.1002/jimd.70224 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 13.07.2026. Verfasst von Rachel S Carling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemical Sciences, Synnovis Analytics, Guy's & St Thomas' NHSFT, London, UK. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Biochemical Sciences, Synnovis Analytics, Guy's & St Thomas' NHSFT, London, UK.
- LGC, the Priestley Centre, Surrey Research Park, Guildford, UK.
- Medical Biochemistry, Immunology & Toxicology, University Hospital of Wales, Cardiff, UK.
ORCID-Profile: Rachel S Carling
Zitieren
APA
Carling, R. S., Whyte, E., & Moat, S. J. (2026). Letter to the Editor in Response to Gondrand Et al. “Real‐Life Application of a Point‐of‐Care Biosensor for Phenylalanine in Patients With Phenylketonuria”. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70224
Vancouver
Carling RS, Whyte E, Moat SJ. Letter to the Editor in Response to Gondrand Et al. “Real‐Life Application of a Point‐of‐Care Biosensor for Phenylalanine in Patients With Phenylketonuria”. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70224
BibTeX
@article{Carling2026,
author = {Carling, Rachel S and Whyte, Emily and Moat, Stuart J},
title = {Letter to the Editor in Response to Gondrand Et al. “Real‐Life Application of a Point‐of‐Care Biosensor for Phenylalanine in Patients With Phenylketonuria”},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {4},
doi = {10.1002/jimd.70224}
}
EUVIMED